URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) method for hypercoagulability/hypocoagulability, and the thrombosis
model, using tissue factor (TF
Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) potent anti-inflammatory efficacy in several disease
models, which could be the potential candidates
salt 2-[
3-methyl-1-npropyl-7-(1,1-dioxothietanil-
3) xantinyl-8-thio]acetic acid (Compound I) under
Ye, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) -induced cardiomyopathy by suppressing JNK-mediated inflammation. High-fat diet (HFD)-induced obesity mouse
modelKhaliullin, F.A.,
Shabalina, Y.V.,
Samorodov, A.V.,
Kamilov, F.K.,
Timirkhanova, G.A.,
Murataev, D.Z. (2018) Reaction of 7-(thietanyl-
3)-, 7-(1-oxothietanyl-
3)-, and 7-(1,1-dioxothietanyl-
3)-8-bromo-
3-methyl
Gurevich, K.G.,
Urakov, A.L.,
Khaliullin, F.A.,
Samorodov, A.V.,
Shabalina, Y.V.,
Kamilov, F.K.,
Murataev, D.Z.,
Bashirova, L.I. (2020) Reactions of 2-[1-ethyl-
3-methyl-7-(thietan-
3-yl)- and 2-[1-ethyl-
3-methyl-7-(1,1-dioxothietan-
3-yl
GUREVICH, K.G.,
URAKOV, A.L.,
KHALIULLIN, F.A.,
SAMORODOV, A.V.,
SHABALINA, Y.V.,
KAMILOV, F.KH.,
MURATAEV, D.Z.,
BASHIROVA, L.I. (2020) Reactions of 2-[1-ethyl-
3-methyl-7-(thietan-
3-yl)- and 2-[1-ethyl-
3-methyl-7-(1,1-dioxothietan-
3-yl